menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.
Visit Cencora

Podcast: The future is bright; the future is CGT

By Lung-I Cheng

podcast
podcast

Raman Sehgal, best-selling author and Founder of global marketing agency specialized in the life science industry, ramarketing, welcomes Vice President, Cell and Gene Therapy, Lung-I Cheng, on his podcast Molecule to Market. 

In this episode, they discuss different models of healthcare and the value they do and don’t deliver to patients, access and infrastructural challenges of CGTs, and what the future looks like for CGT.

podcast

Learn more about our end to end suite of commercialization solutions for biopharma companies

Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers.
Topics:
Cell and gene therapy

About The Author

headshot
Lung-I Cheng
Vice President, Cell and Gene Therapy
Biopharma Services
View Bio

Related Content

Manufacturers

From Potential to Value: Carving a Slice of the CGT ‘PIE'

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2024
Man and woman business meeting

Manufacturers

Essential guide to cell and gene therapy (CGT)  commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2024
Rainbow-Abstract

Manufacturers

Opportunities and pain points for CGT innovation and market access

headshot
Lung-I Cheng
Biopharma Services
February 2024
Cell and gene therapy consultants